155 related articles for article (PubMed ID: 37729244)
1. Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit.
Santos LGD; Santos JGD; Iser BM; Kock KS; Bó KD
Rev Paul Pediatr; 2023; 42():e2023023. PubMed ID: 37729244
[TBL] [Abstract][Full Text] [Related]
2. Prescription of off-label and unlicensed drugs for preterm infants in a neonatal intensive care unit.
Vieira VC; Costa RS; Lima RCG; Queiroz DB; Medeiros DS
Rev Bras Ter Intensiva; 2021; 33(2):266-275. PubMed ID: 34231807
[TBL] [Abstract][Full Text] [Related]
3. Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit.
Gidey MT; Gebretsadkan YG; Tsadik AG; Welie AG; Assefa BT
Ital J Pediatr; 2020 Apr; 46(1):41. PubMed ID: 32245504
[TBL] [Abstract][Full Text] [Related]
4. Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit.
Arocas Casañ V; Cabezuelo Escribano B; Garrido-Corro B; De la Cruz Murie P; Blázquez Álvarez MJ; De la Rubia Nieto MªA
Farm Hosp; 2017 May; 41(3):371-381. PubMed ID: 28478751
[TBL] [Abstract][Full Text] [Related]
5. Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran.
Kouti L; Aletayeb M; Aletayeb SMH; Hardani AK; Eslami K
BMC Pediatr; 2019 Jan; 19(1):3. PubMed ID: 30609923
[TBL] [Abstract][Full Text] [Related]
6. Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study.
Mazhar F; Akram S; Haider N; Hadi MA; Sultana J
Int J Clin Pharm; 2018 Jun; 40(3):700-703. PubMed ID: 29721741
[TBL] [Abstract][Full Text] [Related]
7. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.
Nir-Neuman H; Abu-Kishk I; Toledano M; Heyman E; Ziv-Baran T; Berkovitch M
Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042
[TBL] [Abstract][Full Text] [Related]
8. Use of off-label and unlicensed medicines in neonatal intensive care.
Costa HTML; Costa TX; Martins RR; Oliveira AG
PLoS One; 2018; 13(9):e0204427. PubMed ID: 30252920
[TBL] [Abstract][Full Text] [Related]
9. Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study.
Cuzzolin L; Agostino R
Eur J Clin Pharmacol; 2016 Jan; 72(1):117-23. PubMed ID: 26490354
[TBL] [Abstract][Full Text] [Related]
10. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
[TBL] [Abstract][Full Text] [Related]
11. Off-label and unlicensed drug use among neonatal intensive care units in Southern Italy.
Laforgia N; Nuccio MM; Schettini F; Dell'Aera M; Gasbarro AR; Dell'Erba A; Solarino B
Pediatr Int; 2014 Feb; 56(1):57-9. PubMed ID: 23937449
[TBL] [Abstract][Full Text] [Related]
12. Off-Label and Unlicensed Drug Use in Neonatology: Reality in a Portuguese University Hospital.
Silva J; Flor-de-Lima F; Soares H; Guimarães H
Acta Med Port; 2015; 28(3):297-306. PubMed ID: 26421781
[TBL] [Abstract][Full Text] [Related]
13. Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study.
Kieran EA; O'Callaghan N; O'Donnell CP
Acta Paediatr; 2014 Apr; 103(4):e139-42. PubMed ID: 24397831
[TBL] [Abstract][Full Text] [Related]
14. Off-label and unlicensed drug use in a pediatric intensive care unit of a tertiary care Spanish hospital. A descriptive study.
Camacho Arroyo MT; Rivas Paterna AB; Meneses Monroy A; Cabrera García L; Blázquez González P; Mancebo Salas N; Rodríguez Leal L; Vargas Castrillón E
Arch Argent Pediatr; 2023 Feb; 121(1):e202102550. PubMed ID: 36194689
[TBL] [Abstract][Full Text] [Related]
15. [High prevalence of off-label and unlicensed drug prescribing in a Brazilian intensive care unit].
Ferreira Lde A; Ibiapina Cda C; Machado MG; Fagundes ED
Rev Assoc Med Bras (1992); 2012; 58(1):82-7. PubMed ID: 22392321
[TBL] [Abstract][Full Text] [Related]
16. [Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines].
Costa HTML; Florencio AP; Bezerra PKDV; Cavalcanti JEC; Costa TX; Fernandes FEM; Martins RR
An Pediatr (Engl Ed); 2021 Mar; 94(3):153-160. PubMed ID: 33514478
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
Borges AP; Campos MS; Pereira LR
Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
[TBL] [Abstract][Full Text] [Related]
18. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
19. [Use of off-label drugs in neonatal intensive care].
Sucasas Alonso A; Avila-Alvarez A; Combarro Eiriz M; Martínez Roca C; Yáñez Gómez P; Codias López A; Fernández Trisac JL; Pértega Díaz S
An Pediatr (Engl Ed); 2019 Oct; 91(4):237-243. PubMed ID: 30772271
[TBL] [Abstract][Full Text] [Related]
20. Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study.
Oguz SS; Kanmaz HG; Dilmen U
Int J Clin Pharm; 2012 Feb; 34(1):136-41. PubMed ID: 22234653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
